You are here

Vascular & Endovascular

 - depression

An analysis of U.S. adults older than 50 found that people with high depressive symptoms during consecutive interviews during a two-year period were twice as likely to have a stroke compared with those who had no or few depressive symptoms.

 - hospital_doctor

An analysis of a national registry found there were wide variations in care for patients undergoing carotid artery stenting (CAS) at U.S. hospitals. Based on the researchers’ model, outcomes varied fourfold among hospitals and odds of experiencing a stroke or dying varied by 50 percent for two randomly selected hospitals treating the same patient.

 - brain, stroke

BOSTON—Patients with atrial fibrillation underestimated the risk of stroke but wanted to work with their physicians and caregivers to better manage their disease, according to a survey released on May 13 from the Heart Rhythm Society and the National Stroke Association.

 - hospitalist and patient

Factors in hospitals such as their size and type affect mortality after patients undergo open abdominal aortic aneurysm repair (OAR) or endovascular abdominal aortic aneurysm repair (EVAR), according to a database analysis.

 - bleeding_stroke

After a year, patients with a minor stroke or high-risk transient ischemic attack who received dual antiplatelet therapy with clopidogrel and aspirin had significantly fewer subsequent strokes than patients that took only aspirin. The rates of moderate or severe hemorrhage were similar in the groups.


More Stories

Similar efficacy for embolic protection devices in carotid artery stenting

For patients undergoing elective carotid artery stenting, in-hospital and 30-day stroke and death rates were similar if they received proximal embolic protection devices or distal filter embolic protection devices, according to a study that compared the efficacy of the devices.

FDA clears way for more versatile atherectomy device

The FDA issued clearance for the 4 Fr 1.25 Solid Diamondback 360 Peripheral Orbital Atherectomy System to treat patients with peripheral artery disease.

ED visits for ischemic stroke or TIA decrease 35% over decade

From 2001 to 2011, the rate of emergency department visits for ischemic stroke or transient ischemic attack (TIA) among adults decreased 35 percent, while the percentage of visits that resulted in admission or transfer to a hospital increased 10 percent.

Few nursing home patients benefit from lower limb revascularization

Research puts the value of lower extremity revascularization in nursing home residents with peripheral artery disease in doubt. Overall, 82 percent of these patients at the one-year mark were nonambulatory or had died.

CMS measures to start adjusting for stroke severity in 2016

Upcoming coding will allow the Centers for Medicare & Medicaid Services (CMS) to adjust for stroke severity in quality measures, the American Stroke Association’s council reported in its spring update. It was one of several highlights that the council described as sea changes.

Stuck in time: Stroke centers make little headway in swift care

The needle for door-to-needle times for thrombolytic therapy in stroke patients hasn’t dropped much over a decade, according to a study published online March 31 in Stroke.

Robotic telestroke model takes longer but is as safe as standard care

Patients receiving telestroke care may wait as much as 18 minutes longer for treatment, but safety outcomes may be as good as standard, vascular neurologist stroke alert care. 

Review finds fewer DVT hospitalizations with rivaroxaban

Researchers comparing patients given rivaroxaban or low-molecular weight heparin in a hospital setting found that use of rivaroxaban correlated to a 27 percent reduction in hospital admissions among patients with deep vein thrombosis (DVT).

Pharmacist-physician teams improve patients' blood pressure control

Multidisciplinary teams offer a broader scope of clinical opinions that can change the face of healthcare. In the case of physician-pharmacist teams, blood pressure control at nine months was best among patients monitored by a team, with sustained improvement through 24 months among minorities.

Poor showing for intracranial stent vs. medical therapy … again

For symptomatic intracranial stenosis, aggressive medical therapy appears the best choice. Again. According to the findings from VISSIT, patients receiving intracranial stents were more than twice as likely to have a stroke, transient ischemic attack, intracranial hemorrhage or die within the first 30 days.

Watchman prevails at last, getting FDA's OK

Boston Scientific’s implantable Watchman Left Atrial Appendage Closure Device finally won FDA approval to become an option to long-term warfarin therapy for high-risk patients with nonvalvular atrial fibrillation.

Taking a 5,000-mile ride for stroke prevention

Former Intel executive Sean Maloney set off on a 5,000-mile cycling quest March 22 to raise awareness about stroke prevention. His Heart Across America campaign is a three-month fundraising trek from Palo Alto, Calif., to New York City.

When no statin is best: Reassessing meds at end of life

Sometimes eliminating a drug may be the best way to care for a dying patient. Findings comparing continued and terminated statin therapy in palliative care patients found those who discontinued statins experienced improved quality of life with no significant increase in risk of death.

FDA adds Protégé to list of approved iliac stents

The FDA approved a self-expanding stent system for patients with peripheral artery disease, adding another option for treating blockages in the iliac arteries.

A Stroke of Genius: Gains Seen on Many Fronts at Meeting

The American Stroke Association’s 2015 International Stroke Conference held Feb. 11-13 in Nashville, Tenn., likely lifted many spirits with findings that supported new therapies and identified opportunities to improve patient care.

2014 guidelines greatly expand oral anticoagulation’s ranks

Adopting 2014 guidelines for reducing the risk of stroke in patients with atrial fibrillation would revise the number recommended for oral anticoagulation treatment in the U.S. upwards by 988,500, according to an analysis published online March 2 in JAMA Internal Medicine.

Poor response to statins may signal progression in blocked arteries

Lowered response to statin therapy may indicate more rapidly progressive atherosclerosis, according to a meta-analysis. These patients, representing one-fifth of the study population, were more likely to have significant arterial blockage progression at follow-up than those who responded to treatment.

Men, women with AF get similar but inadequate thromboprophylaxis care

Man or woman, prescription rates for stroke-preventing anticoagulants were no different for patients with nonvalvular atrial fibrillation (AF) in a global study. However, on the whole the same anticoagulation rates showed inadequate thromboprophylaxis in the majority of patients.

CMS allows add-on payments for drug-coated balloons

The Centers for Medicare & Medicaid Services (CMS) has approved supplemental reimbursement for two drug-coated balloons to treat Medicare patients with peripheral artery disease, but the payment applies only to outpatient settings.

FDA recalls two Trellis peripheral devices

The FDA has made a voluntary recall of two peripheral infusion systems into a Class 1 recall.